These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 11567909
1. [Pharmacokinetic properties of platinium derivatives]. Boisdron-Celle M, Lebouil A, Allain P, Gamelin E. Bull Cancer; 2001 Aug; 88 Spec No():S14-9. PubMed ID: 11567909 [Abstract] [Full Text] [Related]
2. Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates. Jacobs SS, Fox E, Dennie C, Morgan LB, McCully CL, Balis FM. Clin Cancer Res; 2005 Feb 15; 11(4):1669-74. PubMed ID: 15746072 [Abstract] [Full Text] [Related]
3. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate. Brouwers EE, Tibben MM, Rosing H, Hillebrand MJ, Joerger M, Schellens JH, Beijnen JH. J Mass Spectrom; 2006 Sep 15; 41(9):1186-94. PubMed ID: 16929560 [Abstract] [Full Text] [Related]
4. Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates. Jacobs S, McCully CL, Murphy RF, Bacher J, Balis FM, Fox E. Cancer Chemother Pharmacol; 2010 Apr 15; 65(5):817-24. PubMed ID: 19662415 [Abstract] [Full Text] [Related]
5. Oxaliplatin: pharmacokinetics and chronopharmacological aspects. Lévi F, Metzger G, Massari C, Milano G. Clin Pharmacokinet; 2000 Jan 15; 38(1):1-21. PubMed ID: 10668856 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin. Sasaki Y, Tamura T, Eguchi K, Shinkai T, Fujiwara Y, Fukuda M, Ohe Y, Bungo M, Horichi N, Niimi S. Cancer Chemother Pharmacol; 1989 Jan 15; 23(4):243-6. PubMed ID: 2647312 [Abstract] [Full Text] [Related]
14. [Pharmacology of platinum compounds: differences between the three molecules and factors of interpatient variability]. Chatelut E. Bull Cancer; 2011 Nov 15; 98(11):1253-61. PubMed ID: 22024542 [Abstract] [Full Text] [Related]
16. Biotransformations of oxaliplatin in rat blood in vitro. Luo FR, Wyrick SD, Chaney SG. J Biochem Mol Toxicol; 1999 Nov 15; 13(3-4):159-69. PubMed ID: 10098901 [Abstract] [Full Text] [Related]
18. Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity. Shord SS, Bernard SA, Lindley C, Blodgett A, Mehta V, Churchel MA, Poole M, Pescatore SL, Luo FR, Chaney SG. Anticancer Res; 2002 Nov 15; 22(4):2301-9. PubMed ID: 12174918 [Abstract] [Full Text] [Related]